Literature DB >> 24924171

MicroRNAs in osteosarcomagenesis.

Lisa A Kafchinski1, Kevin B Jones.   

Abstract

The etiology of osteosarcoma (OS) remains enigmatic. Particular clinical and molecular patterns, observed with high frequency in OS, suggest that it results from some yet-to-be-discovered central driver. How else can biology generate such an aggressive, metastatic, genetically and chromosomally unstable malignancy with virtually no apparent precursor neoplasms that are partway along a disease path toward OS? With this conundrum as a backdrop, the discovery of every new native molecule with power to impact a cell's biology is usually quickly followed by a search to see if this type of molecule contains the key to unlock OS biology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24924171     DOI: 10.1007/978-3-319-04843-7_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

Review 1.  Bone microenvironment signals in osteosarcoma development.

Authors:  Arantzazu Alfranca; Lucia Martinez-Cruzado; Juan Tornin; Ander Abarrategi; Teresa Amaral; Enrique de Alava; Pablo Menendez; Javier Garcia-Castro; Rene Rodriguez
Journal:  Cell Mol Life Sci       Date:  2015-05-03       Impact factor: 9.261

2.  MicroRNA-150 upregulation reduces osteosarcoma cell invasion and metastasis by downregulating Ezrin.

Authors:  Ce Zhan; Cheng Li; Hao Zhang; Hao Tang; Fang Ji; Su-Chi Qiao; Wei-Dong Xu; Zhi-Wei Wang
Journal:  Oncol Lett       Date:  2016-08-25       Impact factor: 2.967

3.  miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma Mg-63 cells by targeting VEGFA.

Authors:  Li Wang; Minhong Shan; Yang Liu; Fengyi Yang; Hongxia Qi; Lijuan Zhou; Lirong Qiu; Yanshuang Li
Journal:  Onco Targets Ther       Date:  2015-09-16       Impact factor: 4.147

4.  MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.

Authors:  Joelle M Fenger; Ryan D Roberts; O Hans Iwenofu; Misty D Bear; Xiaoli Zhang; Jason I Couto; Jaime F Modiano; William C Kisseberth; Cheryl A London
Journal:  BMC Cancer       Date:  2016-10-10       Impact factor: 4.430

5.  Targeting the Wnt/β-catenin pathway in human osteosarcoma cells.

Authors:  Fang Fang; Ashley VanCleave; Ralph Helmuth; Haydee Torres; Kirby Rickel; Hannah Wollenzien; Hongli Sun; Erliang Zeng; Jing Zhao; Jianning Tao
Journal:  Oncotarget       Date:  2018-12-04

6.  Identification of aberrantly expressed of serum microRNAs in patients with hormone-induced non-traumatic osteonecrosis of the femoral head.

Authors:  Biaofang Wei; Wei Wei
Journal:  Biomed Pharmacother       Date:  2015-08-19       Impact factor: 6.529

7.  Analysis of a Preliminary microRNA Expression Signature in a Human Telangiectatic Osteogenic Sarcoma Cancer Cell Line.

Authors:  Gaia Palmini; Cecilia Romagnoli; Simone Donati; Roberto Zonefrati; Gianna Galli; Francesca Marini; Teresa Iantomasi; Alessandra Aldinucci; Gigliola Leoncini; Alessandro Franchi; Giovanni Beltrami; Domenico Andrea Campanacci; Rodolfo Capanna; Maria Luisa Brandi
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

8.  MicroRNA Expression Changes and Integrated Pathways Associated With Poor Outcome in Canine Osteosarcoma.

Authors:  Deanna D Dailey; Ann M Hess; Gerrit J Bouma; Dawn L Duval
Journal:  Front Vet Sci       Date:  2021-04-15

9.  Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.

Authors:  Yong Wang; Xiandong Zeng; Ningning Wang; Wei Zhao; Xi Zhang; Songling Teng; Yueyan Zhang; Zhi Lu
Journal:  Mol Cancer       Date:  2018-05-12       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.